重新定位的他类药物治疗用于预防胆结石病
Søren N Rønborg1, Faiza Qayyum1, Bo K Lauridsen1
1Department of Clinical Biochemistry, Copenhagen University Hospital - Rigshospitalet, Denmark.
Atherosclerosis
|September 11, 2025
概括
通过模仿遗传HMGCR变异的他类药物治疗,因果降低了胆结石疾病 (GSD) 和胆囊切除术的风险. 使用他类药物降低LDL胆固醇可能对预防GSD和预防心肌梗塞一样有效.
科学领域:
- 心血管遗传学 心血管遗传学
- 胃肠病学 胃肠病学
- 药物基因组学 药物基因组学
背景情况:
- 观察性研究表明,他类药物可以降低胆结石病 (GSD) 和胆囊切除术风险.
- 在HMGCR的遗传变异可以模仿他类药物对胆固醇的影响.
- 需要因果推断来确认他类药物对GSD的影响.
研究的目的:
- 测试基因HMGCR变异是否因果降低GSD和胆囊切除风险.
- 评估HMGCR变异对低密度脂蛋白胆固醇 (LDL-C) 的影响.
- 为了比较他类基因变异对GSD和心肌梗塞 (MI) 风险的影响.
主要方法:
- 使用个人参与者数据 (CGPS,UKBB) 的门德尔随机化分析.
- 在HMGCR中的GWAS变体rs12654264A>T作为风险.
- 事件GSD和胆囊切除作为主要终点;MI作为阳性对照.
主要成果:
- 通过使用他类药物降低1SD的LDL-C与减少GSD风险 (OR=0.79-0.84) 和胆囊切除风险 (OR=0.77-0.88) 相关.
- 遗传HMGCR变异分析显示,每1SD较低的LDL-C,GSD (OR=0.63) 和胆囊切除术 (OR=0.68) 的风险显著降低.
- 这些效应与观察到的MI (OR=0.75) 风险降低相当.
结论:
- 类固醇治疗可能因果关系降低了GSD和胆囊切除术的风险.
- 通过他类药物治疗降低LDL-C可能对预防GSD和预防心脏病发作一样有效.
- 遗传证据支持HMGCR在GSD病变发生过程中的因果作用.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Atherosclerosis III: Management
322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
Coronary Artery Disease IV: Preventive Measures
591
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
591
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
358
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
358
Cholesterol: Significance and Regulation
1.3K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.3K
Coronary Artery Disease V: Interprofessional Care
215
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215


